ISBN: 978-981-11-0008-6 DOI: 10.18178/wcse.2016.06.115
Deep Belief Networks for Ligand-Based Virtual Screening of Drug Design
Abstract— Virtual screening (VS) is a computational technique used in drug discovery. Virtual Screening
process usually works by identifying structures that are most likely to bind the target of drug. Virtual
screening is usually based on compound similarity or database docking. Thus, the identification for drug
compounds based on structure classification still remain as a challenging task. The purpose of this research is
to find a new approach for ligand-based virtual screening using machine learning technique. In this paper, the
classification has been done by using Deep Belief Networks (DBN) method. The data from Nicotinamide
Adenine Dinucleotide (NAD) protein target family were used for training and testing the model. This
research used four protein target classes from literature and two protein target classes from DUD-E docking
website. Feature were obtained from molecular fingerprint descriptor. The experiments result show that DBN
method outperform the existing pharmacophore approach.
Index Terms— deep belief networks, deep learning, drug discovery, virtual screening.
Aries Fitriawan, Ito Wasito, Arida Ferti Syafiandini, Mukhlis Amien
Faculty of Computer Science, Universitas Indonesia, INDONESIA
Azminah Azminah, Arry Yanuar
Faculty of Pharmacy, Universitas Indonesia, INDONESIA
Cite: Aries Fitriawan, Ito Wasito, Arida Ferti Syafiandini, Azminah Azminah, Mukhlis Amien, Arry Yanuar, "Deep Belief Networks for Ligand-Based Virtual Screening of Drug Design," Proceedings of 2016 6th International Workshop on Computer Science and Engineering, pp. 655-659, Tokyo, 17-19 June, 2016.